AVDL AVADEL PHARMACEUTICALS PLC Earnings Reports 8-K Filing 2024 - Financial Results Avadel Pharmaceuticals expects to report net product revenue of $19 million for the quarter and $28 million for the year ended December 31, 2023, and anticipates cash, cash equivalents, and marketable securities of approximately $105 million as of that date.Get access to all SEC 8-K filings of the AVADEL PHARMACEUTICALS PLC